Case Report
Published on 08 Oct 2025
Case report: Anlotinib plus oral etoposide: a potential salvage therapy based on insights from EGFR-TKI-resistant SCLC transformation PDX and clinical settings
in Thoracic Oncology
- 509 views
Case Report
Published on 08 Oct 2025
in Thoracic Oncology
Case Report
Published on 08 Oct 2025
in Otorhinolaryngology - Head and Neck Surgery
Original Research
Published on 08 Oct 2025
in Neurological Biomarkers
Original Research
Published on 08 Oct 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Published on 08 Oct 2025
in Addictive Disorders
Original Research
Published on 08 Oct 2025
in Freight Transport and Logistics
Original Research
Published on 08 Oct 2025
in Exercise Physiology
Original Research
Published on 08 Oct 2025
in Renal Pharmacology
Original Research
Published on 08 Oct 2025
in Cardiovascular and Smooth Muscle Pharmacology
Original Research
Published on 08 Oct 2025
in Cancer Genetics
Original Research
Published on 08 Oct 2025
in Cancer Immunity and Immunotherapy
Review
Published on 08 Oct 2025
in Evolutionary Developmental Biology
Original Research
Published on 08 Oct 2025
in Cancer Imaging and Image-directed Interventions
Original Research
Published on 08 Oct 2025
in Obstetric and Pediatric Pharmacology
Perspective
Published on 08 Oct 2025
in Environmental Sensors, Sustainability and Reaching Net-Zero
Original Research
Published on 08 Oct 2025
in Experimental Therapeutics